Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
European Journal of Immunology
|
October 1, 2008
Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo
Rachel Perret, Franca Ronchese
Oncoimmunology
|
December 20, 2013
Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
Sabine Kuhn, Franca Ronchese
Journal of Immune Based Therapies and Vaccines
|
July 31, 2007
CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion
Anders E Pedersen, Franca Ronchese
Cellular & Molecular Immunology
|
May 21, 2020
Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses
Kerry L Hilligan, Franca Ronchese
European Journal of Immunology
|
June 2, 2022
IL-13 in dermal type-2 dendritic cell specialization: From function to therapeutic targeting
Olivier Lamiable, Maia Brewerton, Franca Ronchese
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 7, 2007
Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism
Victoria Watt, Franca Ronchese, David Ritchie
Frontiers in Immunology
|
December 5, 2015
Monocyte-Derived Dendritic Cells Are Essential for CD8(+) T Cell Activation and Antitumor Responses After Local Immunotherapy
Sabine Kuhn, Jianping Yang, Franca Ronchese
International Immunology
|
August 25, 2004
IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo
Joanna M Roberts, Jianping Yang, Franca Ronchese
Lancet (London, England)
|
July 31, 2002
Tumour antigens on tap
Franca Ronchese, Simon Prasad, David S Ritchie
Immunology and Cell Biology
|
July 26, 2017
Fetal dendritic cells give mum a break
Lisa M Connor, Olivier Lamiable, Franca Ronchese
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
European Journal of Immunology
|
October 1, 2008
Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo
Rachel Perret, Franca Ronchese
Oncoimmunology
|
December 20, 2013
Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
Sabine Kuhn, Franca Ronchese
Journal of Immune Based Therapies and Vaccines
|
July 31, 2007
CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion
Anders E Pedersen, Franca Ronchese
Cellular & Molecular Immunology
|
May 21, 2020
Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses
Kerry L Hilligan, Franca Ronchese
European Journal of Immunology
|
June 2, 2022
IL-13 in dermal type-2 dendritic cell specialization: From function to therapeutic targeting
Olivier Lamiable, Maia Brewerton, Franca Ronchese
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 7, 2007
Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism
Victoria Watt, Franca Ronchese, David Ritchie
Frontiers in Immunology
|
December 5, 2015
Monocyte-Derived Dendritic Cells Are Essential for CD8(+) T Cell Activation and Antitumor Responses After Local Immunotherapy
Sabine Kuhn, Jianping Yang, Franca Ronchese
International Immunology
|
August 25, 2004
IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo
Joanna M Roberts, Jianping Yang, Franca Ronchese
Lancet (London, England)
|
July 31, 2002
Tumour antigens on tap
Franca Ronchese, Simon Prasad, David S Ritchie
Immunology and Cell Biology
|
July 26, 2017
Fetal dendritic cells give mum a break
Lisa M Connor, Olivier Lamiable, Franca Ronchese
Page
of 9